Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs

CNS Drugs
Christine Lebrun, Fanny Rocher

Abstract

In the 1990s, the first disease-modifying therapies (DMTs) for multiple sclerosis (MS) were injectable immunomodulatory (IM) drugs, including four different interferon-β preparations and glatiramer acetate. Since 2000, more than 15 immunosuppressant (IS) drugs have been used, with a more or less specific action on inflammation. These include monoclonal antibodies targeting CTL4, the integrin receptor, the interleukin (IL)-2 receptor, CD19, CD20, CD52, and the sphingosine 1 phosphate family. The association between MS and cancer has long been investigated but has led to conflicting results. No studies have reported an increased risk of cancer after long-term exposure to IM. Several reports suggest an increase in cancer risk among MS patients treated with IS such as mitoxantrone, azathioprine and cyclophosphamide. Because of their action on the immune system, and due to a lack of available long-term data, a special warning of the potential risk of cancer accompanies the use of recent IS such as cladribine, fingolimod, natalizumab or alemtuzumab. In most studies, factors such as diet, smoking, solar radiation, and hormone therapy, all of which influence cancer risk, have not been considered. For fingolimod, natalizumab, alemtuzuma...Continue Reading

References

Oct 26, 1991·Lancet·P L YudkinC Milanese
Sep 11, 1991·Acta Neurologica Scandinavica·H MøllerJ H Olsen
Jun 1, 1996·Acta Neurologica Scandinavica·R MidgardH Nyland
May 16, 2002·Blood·Xavier MarietteUNKNOWN Investigators of the Club Rhumatismes et Inflammation
Jan 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T RobakM Całbecka
Mar 9, 2005·Breast Cancer Research and Treatment·Anat AchironZeev Rotstein
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Nete Munk NielsenHenrik Hjalgrim
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
May 4, 2007·The Journal of Clinical Investigation·Jeremy B Swann, Mark J Smyth
Oct 19, 2007·The Cochrane Database of Systematic Reviews·I CasettaG Filippini
Nov 28, 2007·American Journal of Clinical Dermatology·Thomas HerzingerHans Christian Korting
Apr 19, 2008·Multiple Sclerosis : Clinical and Laboratory Research·Christine LebrunArlette Danzon
Oct 15, 2008·Archives of Neurology·Monica M MadrayDavid F Butler
Feb 19, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A A Pace, J P Zajicek
Mar 3, 2009·Multiple Sclerosis : Clinical and Laboratory Research·R Ellis, M Boggild
Sep 4, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·Alessandro F FoisMichael J Goldacre
Dec 19, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Roberto Bergamaschi, Cristina Montomoli
Jan 22, 2010·The New England Journal of Medicine·Ludwig KapposUNKNOWN FREEDOMS Study Group
Jan 22, 2010·The New England Journal of Medicine·Gavin GiovannoniUNKNOWN CLARITY Study Group
Aug 21, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Adam E Handel, Sreeram V Ramagopalan
Jan 12, 2011·Annual Review of Immunology·Matthew D VeselyMark J Smyth
Feb 5, 2011·Journal of Neurology·Christine LebrunMarc Frenay
Aug 17, 2011·Multiple Sclerosis : Clinical and Laboratory Research·R Le BoucP Vermersch
Nov 15, 2011·Neurology·V MartinelliUNKNOWN Italian Mitoxantrone Group
Jun 26, 2012·Brain : a Journal of Neurology·Elaine KingwellHelen Tremlett
May 10, 2013·CNS Drugs·Gilles Edan, Emmanuelle Le Page
Aug 21, 2013·European Journal of Medical Genetics·Carsten HolzmannPeter Meyer
Mar 7, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Elaine KingwellHelen Tremlett
Dec 24, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Ruth Ann MarrieGary Cutter
Jun 26, 2015·Science Translational Medicine·Zainul S HasanaliElliot M Epner
Jun 27, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Jeffrey A CohenUNKNOWN TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group
Jul 30, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Amal P R SamaraweeraNikos Evangelou
Sep 12, 2015·Archives of Dermatological Research·K ReichM Augustin

❮ Previous
Next ❯

Citations

May 17, 2019·Expert Review of Neurotherapeutics·Laura De GiglioCarlo Pozzilli
Feb 15, 2020·Annals of Neurology·Peter AlpingThomas Frisell
Aug 21, 2019·Expert Opinion on Drug Safety·Clara G ChisariFrancesco Patti
Aug 18, 2020·Cancer Immunology, Immunotherapy : CII·Omar Hasan AliLukas Flatz
Apr 4, 2019·Nature Reviews. Neurology·Dalia Rotstein, Xavier Montalban
Apr 16, 2019·Current Opinion in Neurology·Finja SchweitzerClemens Warnke
Sep 26, 2020·Frontiers in Neurology·Melinda Magyari, Per Soelberg Sorensen
Jun 4, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A N Boyko
Jan 31, 2020·Frontiers in Immunology·Esther Melamed, Michael William Lee
May 7, 2020·Current Opinion in Neurology·Lucia MoiolaUwe K Zettl
Aug 18, 2020·Expert Opinion on Drug Safety·Huah Shin NgHelen Tremlett
May 1, 2019·BMJ Case Reports·Yves MichielsSophie Mazellier
Apr 3, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Luca ProsperiniClaudio Gasperini
Mar 14, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alice MariottiniPaolo A Muraro
Apr 27, 2019·Frontiers in Neurology·Emanuele D'AmicoFrancesco Patti
Oct 27, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Luca ProsperiniClaudio Gasperini
Feb 2, 2021·Multiple Sclerosis and Related Disorders·Mayra Gómez-MorenoYolanda Aladro-Benito
Apr 2, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Loredana La MantiaMarco Rovaris
Aug 23, 2021·Multiple Sclerosis and Related Disorders·Nina GryttenØivind Torkildsen
Aug 28, 2021·Pharmacology & Therapeutics·Emanuela Colombo, Cinthia Farina
Jul 8, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Charles DolladilleGilles Defer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Rachel A Farrell, Gavin Giovannoni
© 2022 Meta ULC. All rights reserved